Search form
Search
contact us
Navigation
home
boards
job ratings
cp wire
medtech news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» Volastra Therapeutics
Volastra Therapeutics
Armed with $60M series A and Lilly's backing, Volastra enters clinic via Amgen cancer med
Armed with $60M series A and Lilly's backing, Volastra enters clinic via Amgen cancer med
Fierce Biotech
Volastra Therapeutics
Eli Lilly
funding
sovilnesib
Amgen
cancer
Flag link:
With $44M and Microsoft R&D alliance, Volastra takes aim at metastatic cancers
With $44M and Microsoft R&D alliance, Volastra takes aim at metastatic cancers
MedCity News
Volastra Therapeutics
cancer metastasis
cancer
R&D
Microsoft
funding
Flag link:
